Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks fall on weakening global growth outlook

Tue, 12th Oct 2021 17:09

(Alliance News) - Stocks in London ended lower on Tuesday after the International Monetary Fund downgraded growth forecasts and warned developing countries are being left behind.

The IMF trimmed its 2021 global growth forecast, warning that the failure to distribute vaccines worldwide is worsening the economic divide and darkening prospects for developing nations. Output worldwide is expected to grow 5.9% this year, only slightly lower than projected in July, before slowing to 4.9% in 2022, the report said.

However, in a report published as the IMF and World Bank hold their biannual meetings, the fund said it now expects growth of 5% for the eurozone, compared to just 4.6% in its previous forecast in July.

The single-currency area's growth forecast stands in stark contrast to other major economies for which the IMF downgraded its outlook on Tuesday. It predicted 6% growth in the US, down one point. Output is now forecast at 8% in China.

The IMF said it expects UK output to grow by 6.8% in 2021, down from a previous estimate of 7%.

The FTSE 100 index closed down 16.62 points, or 0.2%, at 7,130.23. The FTSE 250 closed down 18.57 points, or 0.1%, at 22,468.90 and the AIM All-Share closed down 2.78 points, or 0.2%, at 1,206.27.

The Cboe UK 100 ended down 1.2% at 707.60, the Cboe UK 250 closed down 0.2% at 20,246.80 and the Cboe Small Companies ended down 0.4% at 15,468.10.

The CAC 40 stock index in Paris and the DAX 40 in Frankfurt both ended down 0.3%.

Stocks in New York were lower at the London equities close as investors await key US inflation data amid worries over a weakening global growth outlook.

The DJIA was down 0.1%, the S&P 500 index down 0.1% and the Nasdaq Composite down 0.2%.

IG Group's Josh Mahony explained: "Risk-off sentiment has pushed European and US markets lower today, with resurgent fears over rampant inflation and Chinese risks coming back into play. Evergrande may have helped ease fears with recent sales, yet the failure to pay a third round of bond payments in as many weeks provides a reminder that all is not well.

"The IMF has provided a less than encouraging assessment of the global economic outlook, with downgrades to growth forecasts coming as they warned of overvalued markets and increased risks within emerging markets. Easy lending conditions have brought higher valuations, which the IMF see as a major risk as we move towards an inflation-fuelled phase of monetary tightening."

In the FTSE 100, precious metals miners ended in the green amid the risk-off mood, with Polymetal International and Fresnillo up 1.9% and 0.6% respectively.

In addition, Deutsche Bank started coverage on Russia's Polymetal with a Hold rating.

Gold was trading at USD1,763.12 an ounce at the London equities close, firm against USD1,758.25 late Monday.

GlaxoSmithKline closed up 0.9% after Bloomberg reported the drugmaker's consumer arm was drawing interest from private equity firms.

According to Bloomberg, Advent International, CVC Capital Partners and KKR & Co were among potential suitors evaluating the business. Further, Blackstone, Carlyle Group and Permira were also seen as likely suitors for the unit, which could be valued at GBP40 billion.

At the other end of the large-caps, British Airways parent International Consolidated Airlines ended the worst performer, down 3.4% in a negative read-across from peer easyJet.

FTSE 250-listed easyJet lost 3.7% after the budget airline said it expects to report a headline pretax loss for the financial year that ended September 30 of around GBP1.14 billion to GBP1.18 billion, compared to consensus of a GBP1.18 billion loss. The expected headline loss is still larger than the GBP835 million loss posted for financial 2020, which suffered only a half year's impact of the Covid-19 pandemic.

Ryanair closed down 2.2%, Tui down 2.5% and Wizz Air Holdings down 3.8%.

Commenting on easyJet, CMC Markets analyst Michael Hewson said: "The numbers weren't all bad, however today's update also serves to illustrate the challenges facing the industry as we head into another fiscal year which is still likely to be pandemic affected. We've seen a decent rally off the lows this year, however the rebound has been somewhat constrained with the shares pretty much where they were at the start of this year."

Entain closed down 1.7% even as the blue-chip gambling firm backed full-year guidance following a "strong" third quarter.

Net gaming revenue in the third quarter of 2021 was up 4% on a year ago, with online growth of 7% but retail revenue slipping 1%. On a constant currency basis, online growth was 10% and retail registered a 1% rise, resulting in total net gaming revenue growth of 6% for the quarter.

The sports-betting and gaming firm continued to expect 2021 earnings before interest, tax, depreciation and amortisation in line with previous guidance of GBP850 million to GBP900 million.

CMC's Hewson said: "Today's update from Entain appears to encapsulate why US betting giant DraftKings wants to pay USD22 billion for the business... BetMGM also saw a strong quarter, cementing its position as one of the market leaders in its segment, with the company restating its full year guidance of EBITDA between GBP850 million to GBP900 million. It certainly raises the bar further for DraftKings given the performance of BetMGM and given this performance it certainly makes the task of pushing the bid forward much more complicated.

"Entain certainly has plenty of assets, with a strong brand in the UK as well as its other 27 markets. With this in mind MGM is highly unlikely to want to give up its designs on Entain, but if it does it may look to extract a higher price from DraftKings to be even persuaded to do a deal, and that's even before competition authorities stick their noses in, which would seem likely if any deal starts to materialise."

The pound was quoted at USD1.3595 at the London equities close, down from USD1.3625 at the close Monday, despite positive UK labour market data.

The UK unemployment rate eased in line with market expectations, standing at 4.5% in the three months to August versus 4.6% for July.

Growth in average total pay - which includes bonuses - was 7.2%, and regular pay, which strips out bonuses, was 6.0% among employees for the three months to August.

Ahead of the wind-up of the government's pandemic job retention scheme on September 30, the redundancy rate remained around pre-virus levels.

Paul Dales, chief UK economist for Capital Economics, commented: "The further tightening in the labour market and rise in underlying wage growth in August increases the chances of the Bank of England raising interest rates in the coming months despite other evidence that the economic recovery is spluttering."

The euro stood at USD1.1544 at the European equities close, down from USD1.1570 late Monday. Against the yen, the dollar was trading at JPY113.34, up from JPY113.28 late Monday.

Brent oil was quoted at USD83.50 a barrel at the equities close, down from USD83.77 at the close Monday.

The economic events calendar on Wednesday has China trade data overnight, a monthly UK economic growth reading at 0700 BST and US consumer prices at 1330 BST.

The UK corporate calendar on Wednesday has third-quarter results from food delivery firm Just Eat Takeaway, education publisher Pearson and recruiter PageGroup.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.